Endocrinologie Oasis

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Obesity2 trials
• Graves' disease1 trial
• Type 1 diabetes1 trial
• Type 2 diabetes1 trial

Phase

• Phase 33 trials

Status

• Active, not recruiting1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• argenx1 trial

Running trials

• Not yet recruiting

  A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk

  NCT07900633· Phase 3· Eli Lilly and Company· Source

  Contact: Zeina Yared (principal investigator)

• Recruiting

  A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.

  NCT07596849· Phase 3· argenx· Source

  Contact: Zeina Yared, MD

• Active, not recruiting

  A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight

  NCT06962280· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Graves' disease1 recruiting
• Obesity1 recruiting
• Type 2 diabetes1 recruiting